Silverarc Capital Management, LLC Anavex Life Sciences Corp. Put Options Transaction History

Silverarc Capital Management, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$7.65 - $14.43 $498,780 - $940,836	65,200 Added 6.92%	1,007,700 $9.33 Million
Q3 2022 Oct 28, 2022	BUY	$8.9 - $12.86 $226,060 - $326,644	25,400 Added 2.77%	942,500 $9.73 Million
Q2 2022 Jul 25, 2022	BUY	$7.31 - $12.84 $6.7 Million - $11.8 Million	917,100 New	917,100 $9.18 Million

159

31.6M

910K

1.35M

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $352M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.